Integrated Regional Laboratories Pathology Services, LLC
Integrated Regional Laboratories Pathology Services, LLC was paid $76K by Medicaid between Mar 2021 and Nov 2024, across 45 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 15% of everything it billed.
KISSIMMEE, FL 34759
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Florida
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 2,904 | $11K | |
| 2022 | 7,228 | $9K | |
| 2023 | 20,197 | $30K | |
| 2024incomplete | 19,793 | $26K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 15% | 8,120 | 6,454 | $11K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 15% | 1,294 | 1,143 | $11K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 11% | 111 | 107 | $8K |
| 81025 | 5.7% | 3,010 | 2,775 | $4K | |
| 85027 | 5.7% | 10,019 | 7,316 | $4K | |
| 87070 | 4.8% | 1,902 | 1,841 | $4K | |
| 84484 | 4.7% | 2,062 | 1,710 | $4K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 3.9% | 117 | 111 | $3K |
| 81003 | 3.8% | 5,712 | 5,240 | $3K | |
| 84703 | 3.8% | 1,290 | 1,202 | $3K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.4% | 411 | 374 | $3K |
| 84702 | 3.2% | 749 | 626 | $2K |
33 more codes
| 80048 | Basic metabolic panel (calcium, ionized) | 2.6% | 1,715 | $2K |
| 83735 | 1.9% | 2,417 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.6% | 429 | $1K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 272 | $1K |
| 83690 | 1.4% | 2,403 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.3% | 410 | $985.39 |
| 83880 | <1% | 654 | $736.74 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 432 | $712.78 |
| 87040 | <1% | 114 | $662.02 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 758 | $661.33 |
| 87430 | <1% | 139 | $611.40 | |
| 80047 | <1% | 179 | $548.03 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 120 | $520.85 |
| 80061 | Lipid panel | <1% | 164 | $428.51 |
| 87186 | <1% | 255 | $379.64 | |
| 87802 | <1% | 170 | $357.41 | |
| 85379 | <1% | 505 | $315.04 | |
| 85610 | <1% | 674 | $201.39 | |
| 83605 | <1% | 203 | $198.02 | |
| 86140 | <1% | 464 | $166.51 | |
| 81001 | <1% | 745 | $127.83 | |
| 86900 | <1% | 571 | $125.41 | |
| 85730 | <1% | 115 | $113.07 | |
| 86901 | <1% | 570 | $111.51 | |
| 87210 | <1% | 250 | $80.18 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 66 | $75.32 |
| 86850 | <1% | 120 | $73.39 | |
| 87807 | <1% | 47 | $71.85 | |
| 80076 | <1% | 164 | $42.70 | |
| 84132 | <1% | 115 | $32.67 | |
| 84100 | <1% | 42 | $18.04 | |
| 87147 | <1% | 28 | $13.21 | |
| 82077 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.